Log in
NASDAQ:EGRX

Eagle Pharmaceuticals Earnings Date, Estimates & History

$47.51
+0.52 (+1.11 %)
(As of 12/4/2020 12:00 AM ET)
Add
Compare
Today's Range
$46.23
Now: $47.51▼
$47.75
50-Day Range
$45.03
MA: $47.42▼
$51.34
52-Week Range
$33.80
Now: $47.51▼
$62.41
Volume112,486 shs
Average Volume166,805 shs
Market Capitalization$619.06 million
P/E Ratio135.75
Dividend YieldN/A
Beta0.81

Earnings

Eagle Pharmaceuticals (NASDAQ:EGRX) Earnings Information

Eagle Pharmaceuticals last released its quarterly earnings data on November 5th, 2020. The specialty pharmaceutical company reported $1.17 EPS for the quarter, beating analysts' consensus estimates of $0.30 by $0.87. Eagle Pharmaceuticals has generated $1.38 earnings per share over the last year and currently has a price-to-earnings ratio of 135.7. Eagle Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 1st, 2021 based off prior year's report dates.

Eagle Pharmaceuticals Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Eagle Pharmaceuticals (NASDAQ:EGRX) Earnings Estimates

2020 EPS Consensus Estimate: ($0.54)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20201$0.30$0.30$0.30
Q2 20201($0.32)($0.32)($0.32)
Q3 20201$0.02$0.02$0.02
Q4 20201($0.54)($0.54)($0.54)

Eagle Pharmaceuticals (NASDAQ EGRX) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
3/1/2021
(Estimated)		       
11/5/20209/30/2020$0.30$1.17$0.51Transcript
8/10/20206/30/2020$0.24$0.57($0.02)$37.46 million$41.94 millionTranscript
5/11/20203/31/2020$0.22$0.84$1.03$47.76 million$46.02 millionListen
3/2/2020Q4 2019$0.46$0.48$0.29$49.08 million$48.30 millionTranscript
11/12/2019Q3 2019$0.43$0.26$0.07$45.44 million$41.10 millionTranscript
8/8/2019Q2 2019$0.31$0.48$0.48$53.61 million$56.70 millionListen
5/7/20193/31/2019$0.73$1.01$0.62$47.03 million$49.80 millionListen
2/28/2019Q4 2018$0.79$0.86$0.86$54.17 million$56.05 millionN/A
11/1/20189/30/2018$0.91$1.18$0.91$52.70 million$51.34 millionListen
8/7/2018Q2 2018$0.80$0.95$0.17$51.78 million$59.30 millionN/A
5/10/2018Q1 2018$0.68$0.53$0.17$48.88 million$46.60 millionN/A
2/26/2018Q4 2017$1.00$0.84$1.10$53.65 million$46.80 millionTranscript
11/8/2017Q3 2017$0.57$1.07$1.16$51.63 million$63.02 millionN/A
8/9/2017Q2 2017$0.51$0.33$0.38$52.52 million$50.10 millionListen
5/8/2017Q1 2017$1.44$1.42$1.42$70.10 million$76.80 millionListen
3/1/2017Q416$2.24$3.52$3.52$86.13 million$81.10 millionListen
11/9/2016Q316$0.71$0.73$0.73$41.04 million$37.80 millionListen
8/9/2016Q216$0.71$0.80$0.80$43.55 million$40.90 millionN/A
5/9/2016Q116$0.46($0.06)($0.06)$29.07 million$29.60 millionN/A
2/25/2016Q415$0.53$0.07$0.07$20.78 million$18.20 millionListen
11/11/2015Q315($0.56)($0.65)($0.65)$5.07 million$3.30 millionListen
8/11/2015Q215($0.59)($0.53)($0.53)$4.70 million$6.00 millionListen
5/12/2015Q115$1.56$1.31$1.31$3.41 million$36.30 millionListen
2/17/2015Q4 2014($0.39)($0.39)$3.12 million$5.60 millionN/A
12/17/2014Q314($0.49)($0.65)($0.65)$2.90 million$2.81 millionN/A
8/11/2014Q214($0.39)($0.21)($0.21)$3.40 million$5.80 millionN/A
5/14/2014Q114($0.26)($0.36)($0.30)$3.20 million$5.00 millionListen
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 12/5/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.